{"status": "Ok", "redirect_url": "https://galmedpharma.investorroom.com/2026-08-17-Galmed-Announces-First-Time-Results-in-Prostate-Oncology-Studies-Aramchol-Demonstrates-3-4-Fold-Increase-in-Cell-Death-Compared-to-Enzalutamide-XTANDI-R-Alone-in-Prostate-Cancer-Models", "message": "News view counter 886876 successfully enlarged"}